Cardiovascular disease in haemophilia patients: A contemporary issue

Haemophilia

Volumn 16, Issue SUPPL. 3, 2010, Pages 58-66

  Mannucci, P M ^a   Mauser Bunschoten, E P ^b  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Ageing; Cardiovascular diseases; Haemophilia; Haemophilia with inhibitors; Ischaemic heart disease; Life expectancy

Indexed keywords

ACETYLSALICYLIC ACID; BETA1 INTEGRIN; CLOPIDOGREL; GLYCOPROTEIN IIB; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; AGE DISTRIBUTION; AGING; AORTA GRAFT; AORTA VALVE REPLACEMENT; ARTICLE; BARE METAL STENT; CARDIOVASCULAR DISEASE; CAROTID ENDARTERECTOMY; CORONARY ARTERY BYPASS GRAFT; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG SAFETY; ELECTIVE SURGERY; EPIDEMIOLOGICAL DATA; HEART ATRIUM FIBRILLATION; HEMOPHILIA; HEMOPHILIA A; HUMAN; IMMUNOLOGICAL TOLERANCE; ISCHEMIC HEART DISEASE; LIFE EXPECTANCY; LOADING DRUG DOSE; LOW DRUG DOSE; MITRAL VALVE REPAIR; MORTALITY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STABLE ANGINA PECTORIS; TREATMENT DURATION; UNSTABLE ANGINA PECTORIS;

AGED; ATRIAL FIBRILLATION; BLOOD COAGULATION FACTORS; CARDIOVASCULAR DISEASES; FIBRINOLYTIC AGENTS; HEART VALVE DISEASES; HEMOPHILIA A; HEMOSTASIS; HUMANS; LIFE EXPECTANCY; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; THROMBOSIS; TREATMENT OUTCOME;

EID: 77953521031     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2010.02262.x     Document Type: Article

References (22)

1. Definition of an older or elderly person. http://www.who.int/healthinfo/survey/ageingdefnolder/en/index.html, Available at Accessed 14 October, 2009
2. Ershler WB, Longo DL. The biology of aging: the current research agenda. Cancer 1997, 80:1284-93.
3. Siboni SM, Mannucci PM, Gringeri A. Health status and quality of life of elderly persons with severe hemophilia born before the advent of modern replacement therapy. J Thromb Haemost 2009, 7:780-6.
4. Mannucci PM, Schutgens RE, Santagostino E, Mauser-Bunschoten EP. How I treat age-related morbidities in elderly persons with hemophilia. Blood 2009, 114:5256-63.
5. Darby SC, Kan SW, Spooner RJ. Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIV. Blood 2007, 110:815-25.
6. Ikkala E, Helske T, Myllylä G, Nevanlinna HR, Pitkänen P, Rasi V. Changes in the life expectancy of patients with severe haemophilia A in Finland in 1930-79. Br J Haematol 1982, 52:7-12.
7. Mauser-Bunschoten EP, Fransen Van De Putte DE, Schutgens RE. Co-morbidity in the ageing haemophilia patient: the down side of increased life expectancy. Haemophilia 2009, 15:853-63.
8. Plug I, Van Der Bom JG, Peters M. Mortality and causes of death in patients with hemophilia, 1992-2001: a prospective cohort study. J Thromb Haemost 2006, 4:510-6.
9. Darby SC, Keeling DM, Spooner RJ. The incidence of factor VIII and factor IX inhibitors in the hemophilia population of the UK and their effect on subsequent mortality, 1977-99. J Thromb Haemost 2004, 2:1047-54.
10. Hay CR. Factor VIII inhibitors in mild and moderate-severity haemophilia A. Haemophilia 1998, 4:558-63.
11. White B, Cotter M, Byrne M, O'Shea E, Smith OP. High responding factor VIII inhibitors in mild haemophilia - is there a link with recent changes in clinical practice? Haemophilia 2000, 6:113-5.
12. Wenge K. The elderly patient with cardiovascular disease. Heart Dis 2000, 2:31-61.
13. Rosendaal FR, Briët E, Stibbe J. Haemophilia protects against ischaemic heart disease: a study of risk factors. Br J Haematol 1990, 75:525-30.
14. Tuinenburg A, Mauser-Bunschoten EP, Verhaar MC, Biesma DH, Schutgens RE. Cardiovascular disease in patients with hemophilia. J Thromb Haemost 2009, 7:247-54.
15. Kulkarni R, Soucie JM, Evatt BL. Hemophilia Surveillance System Project Investigators. Prevalence and risk factors for heart disease among males with hemophilia. Am J Hematol 2005, 79:36-42.
16. van der Woude JC, Milam JD, Walker WE, Houchin DP, Weiland AP, Cooley DA. Cardiovascular surgery in patients with congenital plasma coagulopathies. Ann Thorac Surg 1988, 46:283-8.
17. Tang M, Wierup P, Terp K, Ingerslev J, Sørensen B. Cardiac surgery in patients with haemophilia. Haemophilia 2009, 15:101-7.
18. Rosendaal FR, Varekamp I, Smit C. Mortality and causes of death in Dutch haemophiliacs, 1973-86. Br J Haematol 1989, 71:71-6.
19. Triemstra M, Rosendaal FR, Smit C, Van der Ploeg HM, Briët E. Mortality in patients with hemophilia. Changes in a Dutch population from 1986 to 1992 and 1973 to 1986. Ann Intern Med 1995, 123:823-7.
20. Chorba TL, Holman RC, Clarke MJ, Evatt BL. Effects of HIV infection on age and cause of death for persons with hemophilia A in the United States. Am J Hematol 2001, 66:229-40.
21. Larsson SA. Life expectancy of Swedish haemophiliacs, 1831-1980. Br J Haematol 1985, 59:593-602.
22. Koumbarelis E, Rosendaal FR, Gialeraki A. Epidemiology of haemophilia in Greece: an overview. Thromb Haemost 1994, 72:808-13.